Tariq Imam

VP, Business Development & Operations & Corporate Counsel at Lisata Therapeutics

Tariq Imam joined Lisata in May 2016. Before joining Lisata, Mr. Imam led business and corporate development functions at specialty pharmaceutical companies; Mist Pharmaceuticals, Akrimax Pharmaceuticals and Rouses Point Pharmaceuticals. Prior to that, Mr. Imam held positions of increasing responsibility at Humana (NYSE: HUM) within the corporate integration/M&A group. Mr. Imam also worked in the corporate finance and strategy division of Orion Health.

Earlier, Mr. Imam’s legal career began at Wachtell Lipton, Rosen & Katz, in the area of mergers and acquisitions, then at the Legal Aid Society, representing clients in civil matters, and later at Clifford Chance, in the areas of corporate restructuring, insolvency and the life sciences sector.

Throughout his career, Mr. Imam has and continues to counsel individuals, pro bono, through private advisement.

Mr. Imam holds an A.B. in Politics from Princeton University, a J.D. from the New York University School of Law and an MBA in Finance from the New York University Stern School of Business.

Location

New York, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Lisata Therapeutics

1 followers

Lisata Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.